Guardant Health (GH) | Stock Overview & Key Data
Guardant Health Performance Comparison
Stock Range
Today's Range
Low: $60.46
High: $63.00
on October 2, 2025
52 Week Range
Low: $20.14
High: $68.00
on October 25, 2024
All-Time High: $181.07 on February 8, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$7.7B
EPS
-3.46
P/E Ratio (TTM)
-17.45
Forward P/E
-22.87
P/B Ratio
-25.24
PEG Ratio
3.66
Div. Yield
N/A
ROE
312.48%
Beta
1.462
Debt to Equity
-4.37
Financial Highlights
Profitability
Gross Margin
65.01%
Operating Margin
-45.75%
Profit Margin
-49.93%
Returns and Earnings
Return on Assets (TTM)
-19.57%
Return on Equity (TTM)
312.48%
EBITDA
$-419.1M
Net Income (TTM)
$-413.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$6.68
Quarterly Revenue Growth (YoY)
30.90%
Quarterly Earnings Growth (YoY)
30.95%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Guardant Health GH | 7.73B Mid-cap | 2.13% | -7.59% | 22.48% | 41.32% | 93.45% | 177.35% | 10.24% | -43.19% |
| Thermo Fisher TMO | 201.36B Mega-cap | 14.32% | 7.68% | 22.72% | 7.34% | 0.46% | -12.30% | 0.26% | 12.97% |
| Danaher DHR | 136.50B Large-cap | 15.91% | 3.21% | 3.87% | 2.52% | -8.48% | -22.11% | -11.63% | 4.95% |
| Qiagen N.V QGEN | 9.69B Mid-cap | 5.26% | -1.45% | -4.93% | 15.54% | 3.86% | 6.13% | 8.77% | -15.53% |
| Charles River CRL | 7.23B Mid-cap | 20.46% | 8.75% | 11.35% | 17.47% | -3.99% | -8.03% | -14.57% | -27.68% |
| RadNet RDNT | 5.96B Mid-cap | 4.27% | 11.41% | 40.75% | 49.17% | 11.66% | 14.07% | 312.48% | 363.49% |
Ownership & Short Interest
Insider Ownership
4.26%
Institutional Ownership
99.10%
Shares Short
9M
Short Ratio
3.67
Short % of Shares Outstanding
7.36%
Average 10-Day Volume
3M
Average 90-Day Volume
2M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GH's 52-week high and low?
- In the last 52 weeks, Guardant Health reached a high of $68.00 (on N/A) and a low of $20.14 (on October 25, 2024).
- What is the market cap and P/E ratio for GH?
- Curious about Guardant Health's size and valuation? Its market capitalization stands at 7.73B. When it comes to valuation, the P/E ratio (trailing twelve months) is -17.45, and the forward P/E (looking ahead) is -22.87.
- Does GH pay dividends? If so, what's the yield?
- As for dividends, Guardant Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Guardant Health's main competitors or similar companies to consider before investing?
When looking at Guardant Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO201.36B Healthcare Diagnostics & Research -12.30% 0.26% Danaher
DHR136.50B Healthcare Diagnostics & Research -22.11% -11.63% Qiagen N.V
QGEN9.69B Healthcare Diagnostics & Research 6.13% 8.77% Charles River
CRL7.23B Healthcare Diagnostics & Research -8.03% -14.57% RadNet
RDNT5.96B Healthcare Diagnostics & Research 14.07% 312.48% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Guardant Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Guardant Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 312.48%, the Debt to Equity ratio from the most recent quarter is -4.37, and its Gross Profit Margin stands at 65.01%.
- What is the recent revenue and earnings growth for GH?
- Looking at Guardant Health's growth, its revenue over the trailing twelve months (TTM) was $829M. Compared to the same quarter last year (YoY), quarterly revenue grew by 30.90%, and quarterly earnings saw a YoY growth of 30.95%.
- How much of GH stock is held by insiders and institutions?
- Wondering who owns Guardant Health stock? Company insiders (like executives and directors) hold about 4.26% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 99.10%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.